The maker of weight loss drugs Ozempic and Wegovy broke rules around the advertising and marketing of its medication to ...

Ozempic-maker Novo Nordisk on Friday ousted its CEO Lars Fruergaard Jorgensen over concerns the company is losing its first-mover advantage in the competitive obesity drug market to American rival Eli ...

The weight loss provided by CagriSema in Phase 3 trials beats current leading products for ... could further erode Novo's lead. FILE PHOTO: A view shows the logo of Novo Nordisk at the company's ...